Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune dysfunction in cancer patients.

Joyce E Ohm1, David P Carbone

  • 1Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.

Oncology (Williston Park, N.Y.)
|February 7, 2002
PubMed
Summary

Cancer patients often experience immune deficiency due to tumor evasion strategies. Vascular endothelial growth factor (VEGF) significantly contributes to these tumor-associated immune deficiencies by impairing immune cell function and development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methylation-based Liquid Biopsy Facilitates Early Detection of Small Cell Transformation in ALK-rearranged Non-Small Cell Lung Cancer.

The oncologist·2026
Same author

Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors.

Journal of Cancer·2026
Same author

Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific Phenotypes.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Immunological consequences of chemotherapy: implications for cancer immunotherapy.

Journal for immunotherapy of cancer·2026
Same author

Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and Brazil.

JTO clinical and research reports·2026

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Immune deficiency is common in cancer patients.
  • Tumor cells employ mechanisms to evade immune responses.
  • These mechanisms involve defective antigen presentation and host recognition.

Purpose of the Study:

  • To review mechanisms of tumor immune evasion.
  • To highlight the role of vascular endothelial growth factor (VEGF) in immune deficiency.

Main Methods:

  • Review of existing literature on tumor immunology and VEGF.
  • Analysis of cellular and molecular mechanisms of immune evasion.

Main Results:

  • VEGF, produced by tumors, inhibits dendritic cell maturation.

Related Experiment Videos

  • VEGF decreases T-cell to B-cell ratios and causes thymic atrophy.
  • These effects mirror immune defects observed in cancer patients.

    • Conclusions:

    • VEGF is a key factor in tumor-induced immune deficiencies.
    • Understanding VEGF's role is crucial for developing cancer immunotherapies.